Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.

  • Authors : Magen O; From the Clalit Research Institute, Innovation Division (O.M., J.G.W., M.M.-A., R.D.B., N.D.), and the Tel-Aviv District, Community Division (R.V.), Clalit Health Services, and the Sackler Faculty of Medicine, Tel-Aviv University (D.D.), Tel Aviv, the Department of Internal Medicine D, Hasharon Hospital Rabin Medical Center, Petah Tikva (D.D.), and the School of Public Health, Faculty of Health Sciences (R.D.B.), and the Department of Software and Information Systems Engineering (N.D.), Ben Gurion University of the Negev, Be'er Sheva - all in Israel; and the Departments of Epidemiology and Biostatistics and CAUSALab (M.A.H.) and the Center for Communicable Disease Dynamics, Departments of Epidemiology and of Immunology and Infectious Diseases (M.L.), Harvard T.H. Chan School of Public Health, the Ivan and Francesca Berkowitz Family Living Laboratory Collaboration at Harvard Medical School and Clalit Research Institute (B.Y.R., R.D.B., N.D.), the Predictive Medicine Group, Computational Health Informatics Program, Boston Children's Hospital (B.Y.R.), and the Departments of Pediatrics (B.Y.R.) and Biomedical Informatics (B.Y.R., N.D.), Harvard Medical School - all in Boston.

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/therapeutic use ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control SARS-CoV-2 variants

  • Source: The New England journal of medicine [N Engl J Med] 2022 Apr 28; Vol. 386 (17), pp. 1603-1614. Date of Electronic Publication: 2022 Apr 13.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Waning of SARS-CoV-2 booster viral-load reduction effectiveness.

  • Authors : Levine-Tiefenbrun M; Faculty of Biology, Technion - Israel Institute of Technology, Haifa, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Subjects: BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*immunology ; COVID-19/COVID-19/COVID-19/*immunology ; COVID-19 Vaccines/COVID-19 Vaccines/COVID-19 Vaccines/*immunology SARS-CoV-2 variants

  • Source: Nature communications [Nat Commun] 2022 Mar 04; Vol. 13 (1), pp. 1237. Date of Electronic Publication: 2022 Mar 04.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Periodical

Studies Suggest COVID-19 Vaccine Boosters Save Lives.

Subjects: BNT162 Vaccine* ; COVID-19 Vaccines* ; Immunization, Secondary* COVID-19 vaccine booster shot

  • Source: JAMA [JAMA] 2022 Jan 11; Vol. 327 (2), pp. 115.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel.

Subjects: COVID-19 Vaccines* ; Immunization, Secondary* ; Long-Term Care*COVID-19 vaccine booster shot

  • Source: The New England journal of medicine [N Engl J Med] 2022 Jan 27; Vol. 386 (4), pp. 399-401. Date of Electronic Publication: 2021 Dec 22.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Audio Interview: Waning Immunity against SARS-CoV-2.

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/supply & distribution ; Immunization, Secondary* SARS-CoV-2 variants

  • Source: The New England journal of medicine [N Engl J Med] 2021 Dec 09; Vol. 385 (24), pp. e99.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

mRNA COVID-19 vaccine safety among older adults from the Canadian National Vaccine Safety Network.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage

  • Source: Vaccine [Vaccine] 2024 Jul 11; Vol. 42 (18), pp. 3819-3829. Date of Electronic Publication: 2024 May 06.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Comparison of homologous and heterologous inactivated and mRNA vaccination programme against SARS-CoV-2 in dialysis patients.

  • Authors : Yasar E; Department of Nephrology, Gazi University, Faculty of Medicine, Ankara, Turkey.; Yildiz Y

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology ; Renal Dialysis*/Renal Dialysis*/Renal Dialysis*/adverse effects

  • Source: Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2024 Jul; Vol. 29 (7), pp. 405-414. Date of Electronic Publication: 2024 Mar 14.Publisher: Blackwell Science Country of Publication: Australia NLM ID: 9615568 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Establishment of human post-vaccination SARS-CoV-2 standard reference sera.

  • Authors : Xiang J; Iowa City Veterans Administration Healthcare System, 601 Highway 6, Iowa City, IA 52246, USA; The University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA.

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology SARS-CoV-2 variants

  • Source: Journal of immunological methods [J Immunol Methods] 2024 Jul; Vol. 530, pp. 113698. Date of Electronic Publication: 2024 May 31.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 1305440 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Neutralizing antibody response to XBB.1.5, BA.2.86, FL.1.5.1, and JN.1 six months after the BNT162b2 bivalent booster.

  • Authors : Favresse J; Clinical Pharmacology and Toxicology Research Unit, Namur Research Institute for Life Sciences, Namur Thrombosis and Hemostasis Center, University of Namur, Namur, Belgium; Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium.

Subjects: Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/blood ; Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/immunology ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood SARS-CoV-2 variants

  • Source: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Jun; Vol. 143, pp. 107028. Date Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3511

Record details

×
Academic Journal

Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology ; Immunocompromised Host*/Immunocompromised Host*/Immunocompromised Host*/immunology

  • Source: The Lancet. Rheumatology [Lancet Rheumatol] 2024 Jun; Vol. 6 (6), pp. e339-e351. Date of Electronic Publication: 2024 May 08.Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101765308 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×